Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/eci.13404

http://scihub22266oqcxt.onion/10.1111/eci.13404
suck pdf from google scholar
32918295!ä!32918295

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32918295      Eur+J+Clin+Invest 2021 ; 51 (1): e13404
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Prognostic implications of neutrophil-lymphocyte ratio in COVID-19 #MMPMID32918295
  • Jimeno S; Ventura PS; Castellano JM; Garcia-Adasme SI; Miranda M; Touza P; Lllana I; Lopez-Escobar A
  • Eur J Clin Invest 2021[Jan]; 51 (1): e13404 PMID32918295show ga
  • BACKGROUND: The clinical presentation of COVID-19 ranges from a mild, self-limiting disease, to multiple organ failure and death. Most severe COVID-19 cases present low lymphocytes counts and high leukocytes counts, and accumulated evidence suggests that in a subgroup of patients presenting severe COVID-19, there may be a hyperinflammatory response driving a severe hypercytokinaemia which may be, at least in part, signalling the presence of an underlying endothelial dysfunction. In this context, available data suggest a prognostic role of neutrophil-lymphocyte ratio (NLR) in various inflammatory diseases and oncological processes. Following this rationale, we hypothesized that NLR, as a marker of endothelial dysfunction, may be useful in identifying patients with a poor prognosis in hospitalized COVID-19 cases. DESIGN: A retrospective observational study performed at Hospital Universitario HM Puerta del Sur, Madrid, Spain, which included 119 patients with COVID-19 from 1 March to 31 March 2020. Patients were categorized according to WHO R&D Expert Group. RESULTS: Forty-five (12.1%) patients experienced severe acute respiratory failure requiring respiratory support. Forty-seven (12.6%) patients died. Those with worse outcomes were older (P = .002) and presented significantly higher NLR at admission (P = .001), greater increase in Peak NLR (P < .001) and higher increasing speed of NLR (P = .003) compared with follow-up patients. In a multivariable logistic regression, age, cardiovascular disease and C-reactive protein at admission and Peak NLR were significantly associated with death. CONCLUSIONS: NLR is an easily measurable, available, cost-effective and reliable parameter, which continuous monitoring could be useful for the diagnosis and treatment of COVID-19.
  • |*Hospital Mortality[MESH]
  • |*Lymphocytes[MESH]
  • |*Neutrophils[MESH]
  • |Age Factors[MESH]
  • |Aged[MESH]
  • |Aged, 80 and over[MESH]
  • |C-Reactive Protein/immunology[MESH]
  • |COVID-19/*blood/immunology/mortality[MESH]
  • |Cardiovascular Diseases/epidemiology[MESH]
  • |Comorbidity[MESH]
  • |Diabetes Mellitus/epidemiology[MESH]
  • |Endothelium, Vascular/physiopathology[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Hypertension/epidemiology[MESH]
  • |L-Lactate Dehydrogenase/blood[MESH]
  • |Leukocyte Count[MESH]
  • |Leukocytosis/*blood/immunology[MESH]
  • |Logistic Models[MESH]
  • |Lymphocyte Count[MESH]
  • |Lymphopenia/*blood/immunology[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Multivariate Analysis[MESH]
  • |Prognosis[MESH]
  • |Pulmonary Disease, Chronic Obstructive/epidemiology[MESH]
  • |Retrospective Studies[MESH]
  • |SARS-CoV-2[MESH]
  • |Severity of Illness Index[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box